Mallesons is pleased to have advised New Hope Corporation Limited (NHC) on its recent issuance of A$300 million senior convertible notes due 2032 (Notes), which are listed on the SGX-ST, and its concurrent repurchase of A$293.3 million of its existing senior convertible notes due 2029 (Existing Notes).
This transaction is the third issuance of SGX-ST-listed convertible notes by NHC that Mallesons has supported on and follows Mallesons’ involvement in similar convertible note issuances and buyback transactions for other listed issuers.
The Mallesons team was led by Partners Karim Issa and Paul Schroder in Australia, together with Capital Markets Partner Andy Ferris providing cross-border coverage between Singapore and Australia. Solicitors Sarah Jones, Mark Teh and Bella Kidman and Graduate Max Green supported in Australia and Associate Jinni Yeo in Singapore.
Commenting on the deal, Karim Issa said:
“The offer and the concurrent repurchase extends NHC’s debt maturity profile, while allowing the company to continue to benefit from low-cost fixed rate funding. It is a great outcome for the company, particularly in light of the broader ongoing geopolitical and market volatility.”
Paul Schroder added:
“Our role on NHC’s capital management exercise reflects our continued market leadership on convertible notes and hybrid offerings by ASX issuers.”
The offer of the new Notes and the concurrent repurchase both settled on 22 April 2026.
